London
A new pain reliever that uses marijuana extracts can be prescribed in Britain, the government said this week. Under the new policy, the drug Sativex can be given to multiple sclerosis patients to relieve pain and spasms. For now, British patients must import their Sativex from Canada. But GW Pharmaceuticals, the company that makes Sativex, has been given a license to cultivate pot in the U.K. and plans to open a factory there. The plants are already being grown at a secret location somewhere in England.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Zohran Mamdani: the young progressive likely to be New York City's next mayorIn The Spotlight The policies and experience that led to his meteoric rise
-
The best film reboots of all timeThe Week Recommends Creativity and imagination are often required to breathe fresh life into old material
-
'More must be done'Instant Opinion Opinion, comment and editorials of the day
